AML Videos

Muhammad Bilal Abid, MD, discusses findings from a retrospective cohort study that compared outcomes of patients with AML who underwent alloHSCT with younger matched unrelated donors vs older matched sibling donors, showing a reduced risk of...

Anna Halpern, MD, presents study findings showing the addition of sorafenib to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) produces high rates of complete remission with MRD negativity in newly diagnosed AML and...

Keith Pratz, MD, provides insights into navigating outpatient combination therapy in newly diagnosed acute myeloid leukemia at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.

Dr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.

Dr Percival provides her insight on how the treatment landscape has evolved thus far for patients with AML, and therapies that are currently in the pipeline.

Courtney DiNardo, MD, discusses the results from the VIALE-A study, which evaluated azacitidine with or without venetoclax in older patients with newly diagnosed AML.

Dr Roboz gives attendees a taste of what's to come at this year's virtual Great Debates & Updates in Hematologic Malignancies.

Naval Daver, MD, discusses the results of a phase 2 study exploring azacitidine plus nivolumab and ipilimumab for patients with relapsed/refractory AML.